Combined therapy in vulvar lichen sclerosus : does topical tretinoin improve the efficacy of mometasone furoate?
Abstrract Purpose: To assess efficacy and safety profile of combining a potent corticosteroid with a retinoid in the treatment of vulvar lichen sclerosus (VLS).
METHODS: We retrospectively compared 21 VLS patients treated with tretinoin (T) in short-contact therapy and mometasone furoate (MMF) (group A) and 20 treated with cold cream (CC) and MMF (group B) for 5 consecutive days/week for 12 weeks. The efficacy parameters were the response rate, the percentage of patients achieving an improvement from baseline of ≥75% in subjective and objective scores and the mean reduction in subjective and objective scores.
RESULTS: Thirteen patients (75.2%) were considered as responders in group A and 15 (78.9%) in group B; 50% and 61.1% of patients in group A and 100% and 63.1% in group B achieved an improvement of at least 75% in subjective and objective scores, respectively. The scheme combining MMF and CC was better tolerated than the combination of MMF and T.
CONCLUSIONS: The combination with a topical retinoid did not enhance the effectiveness of a potent corticosteroid in the treatment of VLS. Either the scarce efficacy of the short-contact therapy regimen or a less favorable safety profile of such combination may account for these findings.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
The Journal of dermatological treatment - 28(2017), 6 vom: 07. Sept., Seite 559-563 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Borghi, Alessandro [VerfasserIn] |
---|
Links: |
---|
Themen: |
04201GDN4R |
---|
Anmerkungen: |
Date Completed 10.01.2018 Date Revised 02.12.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09546634.2016.1277178 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM267476477 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM267476477 | ||
003 | DE-627 | ||
005 | 20231224220750.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09546634.2016.1277178 |2 doi | |
028 | 5 | 2 | |a pubmed24n0891.xml |
035 | |a (DE-627)NLM267476477 | ||
035 | |a (NLM)28024127 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Borghi, Alessandro |e verfasserin |4 aut | |
245 | 1 | 0 | |a Combined therapy in vulvar lichen sclerosus |b does topical tretinoin improve the efficacy of mometasone furoate? |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.01.2018 | ||
500 | |a Date Revised 02.12.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Abstrract Purpose: To assess efficacy and safety profile of combining a potent corticosteroid with a retinoid in the treatment of vulvar lichen sclerosus (VLS) | ||
520 | |a METHODS: We retrospectively compared 21 VLS patients treated with tretinoin (T) in short-contact therapy and mometasone furoate (MMF) (group A) and 20 treated with cold cream (CC) and MMF (group B) for 5 consecutive days/week for 12 weeks. The efficacy parameters were the response rate, the percentage of patients achieving an improvement from baseline of ≥75% in subjective and objective scores and the mean reduction in subjective and objective scores | ||
520 | |a RESULTS: Thirteen patients (75.2%) were considered as responders in group A and 15 (78.9%) in group B; 50% and 61.1% of patients in group A and 100% and 63.1% in group B achieved an improvement of at least 75% in subjective and objective scores, respectively. The scheme combining MMF and CC was better tolerated than the combination of MMF and T | ||
520 | |a CONCLUSIONS: The combination with a topical retinoid did not enhance the effectiveness of a potent corticosteroid in the treatment of VLS. Either the scarce efficacy of the short-contact therapy regimen or a less favorable safety profile of such combination may account for these findings | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Vulvar lichen sclerosus | |
650 | 4 | |a combination regimen | |
650 | 4 | |a mometasone furoate | |
650 | 4 | |a short-contact therapy | |
650 | 4 | |a tretinoin | |
650 | 7 | |a Keratolytic Agents |2 NLM | |
650 | 7 | |a Mometasone Furoate |2 NLM | |
650 | 7 | |a 04201GDN4R |2 NLM | |
650 | 7 | |a Tretinoin |2 NLM | |
650 | 7 | |a 5688UTC01R |2 NLM | |
700 | 1 | |a Minghetti, Sara |e verfasserin |4 aut | |
700 | 1 | |a Toni, Giulia |e verfasserin |4 aut | |
700 | 1 | |a Virgili, Annarosa |e verfasserin |4 aut | |
700 | 1 | |a Corazza, Monica |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of dermatological treatment |d 1992 |g 28(2017), 6 vom: 07. Sept., Seite 559-563 |w (DE-627)NLM088851680 |x 1471-1753 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2017 |g number:6 |g day:07 |g month:09 |g pages:559-563 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09546634.2016.1277178 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2017 |e 6 |b 07 |c 09 |h 559-563 |